| Product Name | Solasodine |
|---|---|
| CAS | 126-17-0 |
| Formula | C27H43NO2 |
| MW | 413.64 |
| Appearance | |
| Melting point | 200-202 °C |
| Boiling point | 537.9±50.0 °C | Condition: Press: 760 Torr |
| PKa | 15.02±0.70 | Condition: Most Acidic Temp: 25 °C |
| Product Name | Solasodine |
|---|---|
| CAS | 126-17-0 |
| Formula | C27H43NO2 |
| MW | 413.64 |
| Appearance | |
| Melting point | 200-202 °C |
| Boiling point | 537.9±50.0 °C | Condition: Press: 760 Torr |
| PKa | 15.02±0.70 | Condition: Most Acidic Temp: 25 °C |
WKQ-0000048
中文名稱：澳洲茄胺
中文別名：茄解啶；澳洲茄次堿；茄解定；澳洲茄銨；(4S,5'R,6aR,6bS,8aS,8bR,9S,10R,11aS,12aS,12bS)-5',6a,8a,9-四甲基-1,3,4,5,6,6a,6b,7,8,8a,8b,9,11a,12,12a,12b-十六氫螺[萘并[2',1':4,5]茚并[2,1-b]呋喃-10,2'-哌啶]-4-醇；茄胺；龍葵；澳州茄胺
英文名稱：Solasodine
英文別名：Solasod-5-en-3β-ol (7CI,8CI);(3β,22α,25R)-Spirosol-5-en-3-ol;Spiro[8H-naphth[2',1':4,5]indeno[2,1-b]furan-8,2'-piperidine], spirosol-5-en-3-ol deriv.;(-)-Solasodine;NSC 178260;NSC 179187;Purapuridine;Solancarpidine;Solasodin;Solasodine;
分子式：C27H43NO2
分子量：413.64
CAS號(hào)：126-17-0
純度：HPLC≥98%
熔點(diǎn)：200-202 °C
沸點(diǎn)：537.9±50.0 °C | Condition: Press: 760 Torr
密度：1.12±0.1 g/cm3 | Condition: Temp: 20 °C Press: 760 Torr
酸系度數(shù)：15.02±0.70 | Condition: Most Acidic Temp: 25 °C
儲(chǔ)存條件：-20℃，干燥、避光、密封
規(guī)格：5mg10mg20mg50mg100mg500mg1g2g等應(yīng)客戶需求包裝
供應(yīng)單位：四川省維克奇生物科技有限公司
供應(yīng)電話：028-81700200/4008005713
四川省維克奇生物科技有限公司生產(chǎn)中藥類標(biāo)準(zhǔn)品和天然植物有效單體，主打中藥對(duì)照品/標(biāo)準(zhǔn)品/天然植物有效單體，化學(xué)合成，抗生素三大板塊。公司推出丹參系列、龍膽系列、蟲(chóng)草系列等，敬請(qǐng)關(guān)注！ 新批次有現(xiàn)貨，歡迎咨詢。
| Drug interaction study of natural steroids from herbs specifically toward human UDP-glucuronosyltransferase (UGT) 1A4 and their quantitative structure activity relationship (QSAR) analysis for prediction | ||
| Source:SCI：PHARMACOLOGICAL RESEARCH | Author:Min Xu | Notes：影響因子：4.816 |
| Reference description | ||
hecogenin (1), diosgenin (2), ruscogenin (3), gitogenin (4), tigogenin (5), solasodine (6), (24S,25S)-3β, 24-di-hydroxy-5α-spirostan (7), dracaenol C (8), 25(27)-dehydroruscogenin (9), (1β, 3β, 14α, 15α, 20R, 22S, 25R)-spirost-5-ene-tetrol (10), peimine (11), peiminine (12), peimisine (13), isoverticine (14), trillin (15), polyphyllin VI (16), polyphyllin VII (17), pallidifloside D (18), prosapogenin A (19), spongipregnoloside A (20), dioscin(21), solasonine (22), solamargine (23), gracillin (24), polyphyllin I(25), timosaponin BII (26), timosaponinA-III(27), ophiopogonin D (28), protobioside (29), (22S,25S)-26-O-β-d-glucopyranosyl-22,25-epoxyfurost-5-en-3β,26-diol-3-O-α-l-rha-mnopyranosyl(1 → 2)-β-d-gluc (30), pallidifloside E (31), parispseudoside (32), methylprotodioscin (33), protodioscin (34), pseudoprotodioscin (35), YS-IX (36), pallidifloside A (37), pallidifloside H (38), digoxin (39), bisdigoxigenin (40), 7β, 14α, 21-tri-hydroxy-diosgenin (41), 12β,14α,21-tri-hydroxy-diosgenin (42), and 11β,14α-di-hydroxyldiosgenin (43) were purchase from Sichuan weikeqi biotechnology company (Sichuan province, China). Pooled human liver microsomes (HLMs, 20 mg/mL) and pooled human primary hepatocytes were purchased from Rild Research Institute for LiverDiseases (Shanghai, China). | ||
